Natiijooyinka Tijaabo Caafimaad oo Cusub oo loogu talagalay Daawaynta Bukaan-socodka COVID-19

0 macno daro 3 | eTurboNews | eTN
Written by Linda Hohnholz

Kintor Pharmaceutical Limited, oo ah shirkad baayooloji ah oo heer-caafimaad ah oo horumarinaysa unugyo yaryar oo cusub iyo daawaynta noolaha, ayaa ku dhawaaqday diiwaangelinta iyo qiyaasta bukaankeedii ugu horreeyay ee Shiinaha ee tijaabinteeda bukaan-socod ee gobollo badan oo III ah (NCT04869228) ee proxalutamide ee daaweynta COVID-19 Bukaan-socodka Bukaan-socodka ee Isbitaalka Dadka Saddexaad ee Shenzhen ee Shiinaha Febraayo 10, 2022.

Tijaabada wejiga III waa kala sooc, laba-indho la'aan, placebo-control, daraasad gobollo badan, loogu talagalay in lagu qiimeeyo waxtarka iyo badbaadada proxalutamide ee bukaan-socodka COVID-19 ee lab. Tijaabada wejiga III waxa ay diiwaan geliyeen ku dhawaad ​​200 oo bukaan oo jooga goobo ay ku jiraan Brazil, Philippines iyo Malaysia. Shiinaha waa mid ka mid ah wadamada muhiimka ah ee ka qayb qaadanaya tijaabadan gobolo badan, oo ay ansixisay Shiinaha NMPA Sebtembar 1, 2021. Goobaha ka qaybqaata tijaabadan Shiinaha waxaa ka mid ah Isbitaalka Beijing Ditan, Isbitaalka Saaxiibtinimada Shiinaha iyo Japan, Sadexaad. Isbitaalka Dadka ee Shenzhen, Xarunta Caafimaadka Dadweynaha Shanghai, Isbitaalka Hangzhou Xixi, Xarunta Caafimaadka Dadweynaha ee Chengdu iyo Isbitaalka Shanaad ee dadka Suzhou.

Dr. Tong Youzhi, aasaasaha, Guddoomiyaha, iyo maamulaha guud ee Kintor Pharma, ayaa faallo ka bixisay, "Waxaan jeclaan lahayn inaan si gaar ah ugu mahadcelinno Madaxweynaha Dr. Hongzhou Lu iyo kooxdiisa ee Isbitaalka Dadka Saddexaad ee Shenzhen ee diiwaangelinta bukaannada ugu horreeya iyo qiyaasta qiyaasta proxalutamide's wejiga III tijaabada caafimaad ee lagu daaweynayo bukaan-socodka COVID-19 ee Shiinaha, taas oo ah tallaabo aad muhiim u ah tijaabadan caafimaad ee gobollo badan. Waxaan sameyn doonaa dadaal kasta si aan ugu martiqaadno goobo badan oo Shiinaha ah si ay ugu biiraan daraasaddan muhiimka ah. Ka sokow, tijaabada caafimaad ee bukaan-jiifka COVID-19 (NCT05009732) ayaa bilaabay diiwaangelinta bukaannada Mareykanka, Ukraine iyo Filibiin, waxayna hadda sameyneysaa baaritaanka bukaannada kahor diiwaangelinta goobaha Shiinaha. Waxaan sidoo kale si firfircoon u wadnaa geeddi-socodka wadamada intiisa kale ee ka qayb qaadanaya tijaabooyinkayaga caafimaad ee gobollo badan.

<

War ku saabsan qoraaga

Linda Hohnholz

Tafatiraha guud ee eTurboNews ku salaysan eTN HQ.

Rukumo
Ogeysii
martida
0 Comments
Jawaabaha Gudaha ah
Eeg dhammaan faallooyinka
0
Waan jeclaan lahaa fikradahaaga, fadlan faallo ka bixi.x
()
x
La wadaag...